ArticleBioengineering (Basel, Switzerland)2025
ClinSegNet: Towards Reliable and Enhanced Histopathology Screening.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In histopathological image segmentation, existing methods often show low sensitivity to small lesions and indistinct boundaries, leading to missed detections. Since, in clinical diagnosis, the consequences of missed detection are more serious than false alarms, this study proposes ClinSegNet, a recall-oriented and human-centred framework for reliable histopathology screening. ClinSegNet employs a composite optimisation strategy, termed HistoLoss, which balances stability and boundary refinement while prioritising recall. An uncertainty-driven refinement mechanism is further introduced to target high-uncertainty cases with limited fine-tuning cost. In addition, a clinical data processing pipeline was developed, where pixel-level annotations were automatically derived from IHC-to-H&E mapping and combined with public datasets, enabling effective training under limited clinical data conditions. Experiments on the NuInsSeg and NuInsSeg-UHS datasets showed that ClinSegNet achieved recall scores of 0.8803 and 0.8917, further improved to 0.8983 and 0.9053 with HITL refinement, while maintaining competitive Dice and IoU. Comparative and ablation studies confirmed the complementary design of the framework and its advantage in capturing small or complex lesions. In conclusion, ClinSegNet provides a clinically oriented, recall-prioritised framework that enhances lesion coverage, reduces the risk of missed diagnosis, and offers both a methodological basis for future human-in-the-loop systems and a feasible pipeline for leveraging limited clinical data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.